Last $64.29 USD
Change Today +0.70 / 1.10%
Volume 92.1K
CRL On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James C. Foster J.D.

Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Strategic Planning & Capital Allocation Committee, Charles River Laboratories International, Inc.
AgeTotal Calculated CompensationThis person is connected to 50 board members in 6 different organizations across 7 different industries.

See Board Relationships
63$7,041,418
As of Fiscal Year 2013

Background*

Mr. James C. Foster, J.D. serves as the President of Charles River Laboratories International Inc and has been its Chairman since June 2000; Mr. Foster has been Chief Executive Officer of Charles River Laboratories International Inc. since 1992. Mr. Foster served as the Chief Executive Officer at Ciphent Inc. He served as Senior Vice President of Strategic Business Development at Accuvant, Inc. since September 2011 and served as Vice President of Strategic Business Development. ...

Read Full Background

Corporate Headquarters*

251 Ballardvale Street
Wilmington, Massachusetts 01887

United States

Phone: 781-222-6000
Fax: --

Board Members Memberships*

1989-Present
Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Strategic Planning & Capital Allocation Committee
1992-Present
Director

Education*

MS
Massachusetts Institute of Technology
Unknown/Other Education
Harvard University
Unknown/Other Education
Yale University
Unknown/Other Education
Northeastern University
MBA
Northeastern University
BA
Lake Forest College
BS
Lake Forest College
JD
Boston University School of Law
BS
Capitol College
Master's Degree
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Salary$1,069,089
Total Annual Compensation$1,069,089

Stock Options*

Restricted Stock Awards$4,013,619
All Other Compensation$103,904
Exercised Options821,683
Exercised Options Value$7,534,545
Exercisable Options245,544
Exercisable Options Value$933,434
Unexercisable Options271,354
Unexercisable Options Value$4,150,956
Total Value of Options$12,618,935
Total Number of Options1,338,581

Total Compensation*

Total Annual Cash Compensation$2,056,456
Total Short Term Compensation$1,069,089
Other Long Term Compensation$4,117,523
Total Calculated Compensation$7,041,418
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRL:US $64.29 USD +0.70

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Josef H. von Rickenbach Founder, Chairman and Chief Executive Officer
PAREXEL International Corporation
$883.3K
Joseph L. Herring Chairman and Chief Executive Officer
Covance Inc.
$1.0M
Ciaran Murray Chief Executive Officer, Director and Chairman of Executive Committee
ICON Public Limited Company
€1.8M
Ge Li Ph.D.Co-Founder, Chairman, Chief Executive Officer, Member of Strategy & Finance Committee and Member of Corporate Governance & Nominations Committee
WuXi PharmaTech (Cayman) Inc.
--
Miroslav Reljanovic M.D.Founder, Owner, Chief Executive Officer and Director
Ergomed Plc
38.0K GBP
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHARLES RIVER LABORATORIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.